German Register of Outpatient Parenteral Antibiotic Therapy
OPATReg
1 other identifier
observational
600
1 country
1
Brief Summary
Many infectious diseases require a therapy that is administered intravenously due to a lack of oral treatments. Affected patients often have to stay weeks or even months in hospital just for receiving their therapy although they do not feel severely unwell. Outpatient parenteral antibiotic therapy (OPAT) allows these patients under certain requirements to get discharged from hospital and apply the antibiotic treatment on their own. For these patients quality of life improves by feeling more comfortable at home and being able to participate in everyday life or even go back to work. For the hospitals a reduced inpatient health care means a clear reduction of costs. The aim of OPATReg is to examine under which conditions the OPAT can be established at different locations of patient care. For this purpose, patients with APAT are to be treated and data collected at 7 university institutions in Germany. All centers have the expertise to provide comprehensive care for patients with infectious diseases, to transfer them from inpatient to outpatient care and to continue to provide care there. If successful, the project should help to identify the potential of OPAT for all of Germany. If positive effects and feasibility can be demonstrated OPAT could become an important therapy option with many advantages for certain patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 28, 2020
CompletedFirst Posted
Study publicly available on registry
June 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedNovember 5, 2020
November 1, 2020
3.7 years
May 28, 2020
November 3, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Number of Patients with effective OPAT
Successful administration and completion of the antiinfective therapy
12 weeks
Number of Patients With Treatment-Related Adverse Events
side-effects of treatment and catheter-related infections
12 weeks
Number of Hospitals being able to apply OPAT
Feasibility of OPAT under differing hospital specific circumstances
12 weeks
Study Arms (1)
Outpatient parenteral antimicrobial therapy
Patients with an infectious disease that receive an outpatient parenteral antimicrobial therapy
Interventions
Application of outpatient parenteral antibiotic therapy in patients with infectious diseases to allow them to get discharged from hospital.
Eligibility Criteria
Adults getting OPAT in one of the participating study sites
You may qualify if:
- patients who get OPAT
You may not qualify if:
- patients who don't get OPAT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Cologne
Cologne, 50937, Germany
Study Officials
- STUDY CHAIR
Clara Lehmann, Prof.
Head of Outpatient Department in ID, University Hospital of Cologne
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of outpatient clinic
Study Record Dates
First Submitted
May 28, 2020
First Posted
June 2, 2020
Study Start
October 1, 2019
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
November 5, 2020
Record last verified: 2020-11